Our institute provides in-depth GMP-grade peptide synthesis and manufacturing services to partners worldwide. We specialize in the development of peptides of wide lengths and complexities, utilizing state-of-the-art equipment. Our experienced team ensures exceptional product quality throughout every stage of the process, from conception to delivery

Viking Therapeutics has formed a mutually beneficial alliance with U.S. biopharmaceutical companies to develop and manufacture its GLP-1 drug candidate, VK2735. This marks a significant advancement in securing dependable production capabilities for these vital therapeutic agents. The agreement enables them to handle large-scale peptide manufacturin